Quarterly Result6 Aug 2026, 01:45 pm
Krebs Biochemicals Declares Q1 FY27 Unaudited Financial Results
AI Summary
Krebs Biochemicals & Industries Ltd announced the outcome of its Board Meeting held on August 6, 2026. The board approved and took on record the unaudited financial results for the first quarter ended June 30, 2026, along with the Limited Review Report by the auditors. The company's manufacturing unit in Vizag remains closed following an order from the Andhra Pradesh Pollution Control Board. The board also approved the amalgamation of Krebs Biochemicals with Ipca Laboratories Limited, with an appointed date of April 1, 2026.
Key Highlights
- Board approved unaudited Q1 FY27 financial results.
- Limited Review Report by auditors also approved.
- Vizag manufacturing unit remains closed.
- Amalgamation with Ipca Laboratories approved.
- Appointed date for amalgamation is April 1, 2026.
Price Impact
More from KREBSBIO